EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Impact of coronary artery tortuosity on outcomes following stenting with newer-generation drug-eluting stents. An analysis of the randomized BIOFLOW trials

Nader Mankerious, Ralph Toelg, Mohammad Abdelghani, Hector M Garcia-Garcia, Serdar Farhan, Abdelhakim Allali, Stephan Windecker, Thierry Lefèvre, Shigeru Saito, David E Kandzari, Ron Waksman, Gert Richardt und 1 weitere

Revista Española de Cardiología (English Edition) · 2025

DOI: 10.1016/j.rec.2024.12.009 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von Nader Mankerious und 12 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center Bad Segeberg, Segeberger Kliniken GmbH, Bad Segeberg, Germany; Cardiology Department, Zagazig University, Sharkia, Egypt. Electronic add…. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Percutaneous Coronary Intervention, Coronary Artery Disease, Coronary Vessels. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Patients undergoing percutaneous coronary intervention in vessels with moderate-to-severe tortuosity are at higher risk of adverse outcomes, but data are scarce in the era of newer-generation stents. We compared outcomes following percutaneous coronary intervention in vessels with moderate-to-severe tortuosity using a bioresorbable-polymer sirolimus-eluting stent (BP-SES) vs a durable-polymer everolimus-eluting stent (DP-EES). METHODS: A total of 2350 patients from the BIOFLOW II, IV, and V randomized trials were stratified into 2 groups based on target-vessel tortuosity: none-to-mild and moderate-to-severe. The primary endpoints included target lesion failure (TLF)-a composite of cardiac death, target-vessel myocardial infarction (TV-MI), or ischemia-driven target lesion revascularization (TLR)-and probable/definite stent thrombosis at 3 years. RESULTS: Patients with moderate-to-severe tortuosity (n=903) had more comorbidities than those with none-to-mild tortuosity (n=1447). Rates of TLF (P=.354), cardiac death (P=.690), TLR (P=.447), and stent thrombosis (P=.084) were similar between the 2 groups, whereas TV-MI occurred more frequently in the moderate-to-severe tortuosity group (P=.031). However, on multivariate analysis, moderate-to-severe tortuosity was not an independent predictor of TV-MI (adjusted HR, 1.06; 95% CI, 0.72-1.55; P=.772). Among patients with moderate-to-severe tortuosity, the use of BP-SES was associated with significantly lower rates of TLF compared with the DP-EES (7.8% vs 13.4%; HR, 0.57; 95% CI, 0.37-0.87; P=.009), driven by reductions in TV-MI (5.0% vs 9.2%; HR, 0.54; 95% CI, 0.32-0.90; P=.018) and TLR (2.7% vs 6.1%; HR, 0.45; 95% CI, 0.23-0.90; P=.021). CONCLUSIONS: This pooled analysis of the randomized BIOFLOW trials demonstrates that patients with none-to-mild and moderate-to-severe tortuosity have comparable long-term adverse event rates. However, the use of BP-SES in patients with moderate-to-severe tortuosity may help mitigate potential ischemic risks. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov NCT01356888, NCT01939249, NCT02389946.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsPercutaneous Coronary InterventionCoronary Artery DiseaseCoronary VesselsHumansMaleFemaleAgedMiddle AgedSirolimusTreatment OutcomeCoronary AngiographyProsthesis DesignRandomized Controlled Trials as TopicEverolimusFollow-Up Studies

Stichwörter der Autor:innen

BIOFLOWCoronary tortuosityIntervención coronaria percutáneaNewer-generation drug-eluting stentOrsiroPercutaneous coronary interventionStents farmacoactivos de nueva generaciónTortuosidad coronariaXience

Substanzen

SirolimusEverolimus

Autor:innen und Institutionen

  • Heart Center Bad Segeberg, Segeberger Kliniken GmbH, Bad Segeberg, Germany; Cardiology Department, Zagazig University, Sharkia, Egypt. Electronic address: https://twitter.com/@MankeriousNader.
  • Heart Center Bad Segeberg, Segeberger Kliniken GmbH, Bad Segeberg, Germany; Center for Cardiovascular and Diabetes Medicine, Asklepios Clinic, Bad Oldesloe, Germany; Medical Faculty of the Christian-Albrechts University…
  • Cardiology Unit, Sohar Hospital, Sohar, Oman; Cardiology Department, Al-Azhar University, Cairo, Egypt; Cardiology Department, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands. El…
  • Interventional Cardiology, Medstar Washington Hospital Center, Washington DC, United States. Electronic address: https://twitter.com/@hect2701.
  • Icahn School of Medicine at Mount Sinai, The Zena and Michael A. Wiener Cardiovascular Institute, New York, United States.
  • Department of Cardiology, Medical University of Lübeck, Lübeck, Germany.

Förderung

  • Medical University of Vienna

Zitieren

APA

Mankerious, N., Toelg, R., Abdelghani, M., Garcia-Garcia, H. M., Farhan, S., Allali, A., Windecker, S., Lefèvre, T., Saito, S., Kandzari, D. E., Waksman, R., Richardt, G., & Hemetsberger, R. (2025). Impact of coronary artery tortuosity on outcomes following stenting with newer-generation drug-eluting stents. An analysis of the randomized BIOFLOW trials. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2024.12.009

Vancouver

Mankerious N, Toelg R, Abdelghani M, Garcia-Garcia HM, Farhan S, Allali A, et al. Impact of coronary artery tortuosity on outcomes following stenting with newer-generation drug-eluting stents. An analysis of the randomized BIOFLOW trials. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2024.12.009

BibTeX
@article{Mankerious2025,
  author = {Mankerious, Nader and Toelg, Ralph and Abdelghani, Mohammad and Garcia-Garcia, Hector M and Farhan, Serdar and Allali, Abdelhakim and Windecker, Stephan and Lefèvre, Thierry and Saito, Shigeru and Kandzari, David E and Waksman, Ron and Richardt, Gert and Hemetsberger, Rayyan},
  title = {Impact of coronary artery tortuosity on outcomes following stenting with newer-generation drug-eluting stents. An analysis of the randomized BIOFLOW trials},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2025},
  doi = {10.1016/j.rec.2024.12.009}
}
Kostenlos starten →